CORONAVIRUS DISEASE 2019 (COVID-19) TREATMENT GUIDELINES

The guidance is based on proper case management aspects intended for clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen frontline clinical management and the public health response.

Screening and Triaging of COVID -19

Screening and triaging for COVID-19 aim to interrupt transmission by rapidly identifying suspected cases, sorting and testing patients appropriately, providing timely and appropriate care, and preventing complications and mortality.

Introduction COVID-19

This guideline provides a comprehensive clinical care pathway for patients with COVID-19, from screening and identification through treatment, monitoring, and discharge from care.

Initial patient approach for COVID-19

Early clinical evaluation of patients with suspected or confirmed COVID-19 must prioritize staff safety, rapid stabilization, and identification of life-threatening conditions.

Management based on disease severity COVID-19

There is no single curative (“magic-bullet”) therapy for COVID-19 because the illness is a multi-phase viral-inflammatory syndrome. Effective management therefore requires stage-specific therapy tailored to the phase of illness, appropriate organ support, prevention of thrombosis, and careful monitoring for any signs of clinical deterioration.

Respiratory management COVID-19

Hypoxaemia is the most life-threatening complication of COVID-19. The cornerstone of treatment is timely oxygen therapy and escalation of respiratory support to prevent progression to Acute Respiratory Distress Syndrome.